Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murugesan Vanangamudi

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Drug Discovery Today|April 15, 2022
Repurposing drugs targeting epidemic virusesVigneshwaran Namasivayam, Senthikumar Palaniappan, Murugesan Vanangamudi
Current Opinion in Pharmacology|November 17, 2020
Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief overview of clinically approved drugs and combination regimensMurugesan Vanangamudi, Sonali Kurup, Vigneshwaran Namasivayam
Current Medicinal Chemistry|July 8, 2017
HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: SAR and Lead Optimization Using CoMFA and CoMSIA Studies (1995-2016)Murugesan Vanangamudi, Vasanthanathan Poongavanam, Vigneshwaran Namasivayam
Drug Discovery Today|May 21, 2026
Pharmacomicrobiomics and the gut-brain axis: microbial modulation of drug response in brain disordersAnitha Kuttiappan, Murugesan Vanangamudi, Sumel Ashique, et al.
Viruses|October 28, 2023
Strategies in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)Murugesan Vanangamudi, Senthilkumar Palaniappan, Muthu Kumaradoss Kathiravan, et al.
Advances in Experimental Medicine and Biology|July 14, 2021
Structural Insights to Human Immunodeficiency Virus (HIV-1) Targets and Their InhibitionMurugesan Vanangamudi, Pramod C Nair, S E Maida Engels, et al.
Journal of Ayurveda and Integrative Medicine|September 7, 2024
Hepatoprotective effect of flavonoid rich fraction of Sesbania grandiflora: Results of In vivo, in vitro, and molecular docking studiesAnitha Kuttiappan, Santenna Chenchula, Murugesan Vanangamudi, et al.
3 Biotech|May 25, 2026
From nutrients to health outcomes: integrating diet, disease risk, and lifelong wellnessMonika Kaushik, Murugesan Vanangamudi, Sumit Sharma, et al.
Advances in Immunology|July 30, 2025
Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA & mRNA vaccine in cancer immunotherapyMonika Kaushik, Prathap Madeswaraguptha, Murugesan Vanangamudi, et al.
Current Neuropharmacology|May 21, 2026
Mitochondrial Function in Neurons and Glia in Health and Its Alteration in Parkinson's Disease: A ReviewMonika Kaushik, Mrugendra Potdar, Prathap Madeswaraguptha, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|April 15, 2022
Repurposing drugs targeting epidemic virusesVigneshwaran Namasivayam, Senthikumar Palaniappan, Murugesan Vanangamudi
Current Opinion in Pharmacology|November 17, 2020
Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief overview of clinically approved drugs and combination regimensMurugesan Vanangamudi, Sonali Kurup, Vigneshwaran Namasivayam
Current Medicinal Chemistry|July 8, 2017
HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: SAR and Lead Optimization Using CoMFA and CoMSIA Studies (1995-2016)Murugesan Vanangamudi, Vasanthanathan Poongavanam, Vigneshwaran Namasivayam
Drug Discovery Today|May 21, 2026
Pharmacomicrobiomics and the gut-brain axis: microbial modulation of drug response in brain disordersAnitha Kuttiappan, Murugesan Vanangamudi, Sumel Ashique, et al.
Viruses|October 28, 2023
Strategies in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)Murugesan Vanangamudi, Senthilkumar Palaniappan, Muthu Kumaradoss Kathiravan, et al.
Advances in Experimental Medicine and Biology|July 14, 2021
Structural Insights to Human Immunodeficiency Virus (HIV-1) Targets and Their InhibitionMurugesan Vanangamudi, Pramod C Nair, S E Maida Engels, et al.
Journal of Ayurveda and Integrative Medicine|September 7, 2024
Hepatoprotective effect of flavonoid rich fraction of Sesbania grandiflora: Results of In vivo, in vitro, and molecular docking studiesAnitha Kuttiappan, Santenna Chenchula, Murugesan Vanangamudi, et al.
3 Biotech|May 25, 2026
From nutrients to health outcomes: integrating diet, disease risk, and lifelong wellnessMonika Kaushik, Murugesan Vanangamudi, Sumit Sharma, et al.
Advances in Immunology|July 30, 2025
Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA & mRNA vaccine in cancer immunotherapyMonika Kaushik, Prathap Madeswaraguptha, Murugesan Vanangamudi, et al.
Current Neuropharmacology|May 21, 2026
Mitochondrial Function in Neurons and Glia in Health and Its Alteration in Parkinson's Disease: A ReviewMonika Kaushik, Mrugendra Potdar, Prathap Madeswaraguptha, et al.
Pageof 2